Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Kaken Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 16, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	144,682	176,794	130,992	138,463	147,114	166,112
Market Cap Growth	34.97%	34.97%	-5.40%	-5.88%	-11.44%	-15.14%
Enterprise Value	78,447	100,891	68,690	72,334	84,580	101,291
Last Close Price	3821.00	4481.00	3304.77	3385.04	3424.40	3685.76
PE Ratio	10.46	12.68	16.32	25.45	15.41	12.39
Forward PE	45.97	22.01	19.39	13.57	13.10	13.02
PS Ratio	1.54	1.88	1.82	1.90	1.94	2.22
PB Ratio	0.95	1.16	0.91	1.01	1.06	1.22
P/TBV Ratio	1.09	1.33	0.96	1.07	1.14	1.23
P/FCF Ratio	5.64	6.90	182.95	19.06	14.21	13.39
P/OCF Ratio	4.86	5.94	50.83	14.96	11.03	11.55
EV/Sales Ratio	0.83	1.07	0.95	0.99	1.11	1.35
EV/EBITDA Ratio	3.33	4.28	5.60	6.85	4.33	5.04
EV/EBIT Ratio	3.73	4.80	7.22	9.04	4.96	5.69
EV/FCF Ratio	3.06	3.94	95.94	9.96	8.17	8.16
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	0.16	0.16	0.31	0.36	0.20	0.19
Debt / FCF Ratio	0.15	0.15	5.38	0.53	0.37	0.31
Asset Turnover	0.52	0.52	0.43	0.44	0.46	0.47
Inventory Turnover	1.96	1.96	2.05	2.19	2.28	2.48
Quick Ratio	3.01	3.01	4.68	4.49	4.98	4.60
Current Ratio	3.67	3.67	5.62	5.27	5.81	5.34
Return on Equity (ROE)	9.41%	9.41%	5.72%	3.95%	6.96%	10.13%
Return on Assets (ROA)	7.26%	7.26%	3.52%	3.02%	6.49%	6.92%
Return on Capital (ROIC)	8.65%	8.65%	4.13%	3.54%	7.56%	8.16%
Return on Capital Employed (ROCE)	13.10%	13.10%	6.20%	5.50%	11.70%	12.50%
Earnings Yield	9.64%	7.89%	6.13%	3.93%	6.49%	8.07%
FCF Yield	17.72%	14.50%	0.55%	5.25%	7.03%	7.47%
Dividend Yield	5.00%	3.35%	4.54%	4.43%	4.38%	4.07%
Payout Ratio	51.62%	51.62%	70.49%	103.84%	59.84%	43.35%
Buyback Yield / Dilution	-1.13%	-1.13%	-0.44%	1.07%	1.59%	1.41%
Total Shareholder Return	3.87%	2.22%	4.10%	5.50%	5.97%	5.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.